SCHEMBL16503759

SCHEMBL16503759

Cc1cc(Br)cc(C(=O)NC(C)C)c1NC(=O)c1sc(Cn2nnc(C(F)(F)F)n2)nc1-c1ccccc1Cl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.34
▸ LMNA P02545 4/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ DGAT2 Q96PD7 2/20 0.33
▸ MAPT P10636 3/20 0.33
▸ TP53 P04637 1/20 0.33
▸ TSHR P16473 2/20 0.32
▸ CDC7 O00311 1/20 0.32
▸ DBF4 Q9UBU7 1/20 0.32
▸ HPGD P15428 3/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ PPARG P37231 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ NCOA2 Q15596 1/20 0.31
▸ LCK P06239 1/20 0.31
▸ CNR1 P21554 2/20 0.31
▸ USP2 O75604 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ RORB Q92753 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16503740 0.94 ALDH1A1 (0.35) ALDH1A1LMNAKMT2ADGAT2TSHR
SCHEMBL16503727 0.92 MAPT (0.34) ALDH1A1LMNADGAT2MAPTTP53
SCHEMBL16503761 0.91 HPGD (0.37) ALDH1A1LMNAKMT2ADGAT2MAPT
SCHEMBL16503721 0.91 MAPT (0.34) ALDH1A1LMNAMAPTTP53CDC7
SCHEMBL16503760 0.90 SLC2A1 (0.35) ALDH1A1LMNAKMT2AMAPTTSHR
SCHEMBL16503726 0.89 MAPT (0.33) ALDH1A1LMNAKMT2ADGAT2MAPT
SCHEMBL16503758 0.86 F10 (0.36) ALDH1A1LMNAKMT2ADGAT2MAPT
SCHEMBL16503762 0.85 HPGD (0.39) ALDH1A1LMNAKMT2ADGAT2TSHR
SCHEMBL16503732 0.85 F10 (0.35) ALDH1A1LMNAHPGDNPC1RAB9A
SCHEMBL16503745 0.84 TSHR (0.34) ALDH1A1LMNAKMT2ADGAT2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8980886-B2 Anthranilic acid derivatives BAYER CROPSCIENCE AG (DE) 2015-03-17 — — US disclosed
US-8980886-B2 Anthranilic acid derivatives BAYER CROPSCIENCE AG (DE) 2015-03-17 — — US disclosed
US-20110312953-A1 ANTHRANILIC ACID DERIVATIVES BAYER CROPSCIENCE AG (DE) 2011-12-22 — — US disclosed
US-20110312953-A1 ANTHRANILIC ACID DERIVATIVES BAYER CROPSCIENCE AG (DE) 2011-12-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312953-A1 ANTHRANILIC ACID DERIVATIVES ANTXR2, NQO2, ACLY ALDH1A1 1044/4885LMNA 3176/4885KMT2A 1460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback